These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1701448)

  • 21. Overcoming unresponsiveness in experimental autoimmune encephalomyelitis (EAE) resistant mouse strains by adoptive transfer and antigenic challenge.
    Shaw MK; Zhao XQ; Tse HY
    J Vis Exp; 2012 Apr; (62):e3778. PubMed ID: 22507967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of chronic relapsing experimental allergic encephalomyelitis with the intravenous administration of splenocytes coupled to encephalitogenic peptide 91-103 of myelin basic protein.
    Su XM; Sriram S
    J Neuroimmunol; 1991 Nov; 34(2-3):181-90. PubMed ID: 1717504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressive activity of long-term myelin basic protein-specific SJL T cell lines.
    Barzaga-Gilbert ME; Skeen MJ; Chou CH; Fritz RB
    J Neuroimmunol; 1989 Aug; 23(3):241-7. PubMed ID: 2473998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delineation of two encephalitogenic myelin basic protein epitopes for DA rats.
    Smeltz RB; Wolf NA; Swanborg RH
    J Neuroimmunol; 1998 Jul; 87(1-2):43-8. PubMed ID: 9670844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant.
    Fritz RB; Chou CH; McFarlin DE
    J Immunol; 1983 Jan; 130(1):191-4. PubMed ID: 6183347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein.
    Clayton JP; Gammon GM; Ando DG; Kono DH; Hood L; Sercarz EE
    J Exp Med; 1989 May; 169(5):1681-91. PubMed ID: 2469764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T and B cell responses to myelin basic protein and encephalitogenic epitopes.
    Gould KE; Swanborg RH
    J Neuroimmunol; 1993 Jul; 46(1-2):193-8. PubMed ID: 7689588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis.
    Myers KJ; Sprent J; Dougherty JP; Ron Y
    J Neuroimmunol; 1992 Nov; 41(1):1-8. PubMed ID: 1281165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
    Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
    J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein.
    Voskuhl RR; Farris RW; Nagasato K; McFarland HF; Dalcq MD
    J Neuroimmunol; 1996 Nov; 70(2):103-11. PubMed ID: 8898718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein.
    Zamvil SS; Mitchell DJ; Moore AC; Schwarz AJ; Stiefel W; Nelson PA; Rothbard JB; Steinman L
    J Immunol; 1987 Aug; 139(4):1075-9. PubMed ID: 2440944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning of myelin basic protein-reactive T cells from the experimental allergic encephalomyelitis-resistant rat strain, LER.
    Blankenhorn EP; Stranford SA; Martin AM; Hickey WF
    J Neuroimmunol; 1995 Jun; 59(1-2):173-83. PubMed ID: 7541054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides.
    Tselios T; Daliani I; Probert L; Deraos S; Matsoukas E; Roy S; Pires J; Moore G; Matsoukas J
    Bioorg Med Chem; 2000 Aug; 8(8):1903-9. PubMed ID: 11003134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synthetic 87-99 peptide of myelin basic protein is encephalitogenic in Buffalo rats.
    Jones RE; Bourdette D; Offner H; Vandenbark AA
    J Neuroimmunol; 1992 Apr; 37(3):203-12. PubMed ID: 1373154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis.
    Mor F; Cohen IR
    J Clin Invest; 1993 Nov; 92(5):2199-206. PubMed ID: 7693759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen processing of myelin basic protein is required prior to recognition by T cells inducing EAE.
    Cross AH; Dolich S; Raine CS
    Cell Immunol; 1990 Aug; 129(1):22-31. PubMed ID: 1694732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system.
    Vandenbark AA; Vainiene M; Celnik B; Hashim G; Offner H
    J Neuroimmunol; 1992 Aug; 39(3):251-60. PubMed ID: 1379608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
    Bouwer HG; Hinrichs DJ
    J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.